News | Artificial Intelligence | December 14, 2023

AMA: Physicians Enthusiastic but Cautious About Healthcare AI

New research sheds light on physician motivations, concerns, requirements and uses of AI
 

New research sheds light on physician motivations, concerns, requirements and uses of AI

Getty Images


December 14, 2023 — Physicians are enthusiastic about augmented intelligence (AI) - often called artificial intelligence - and its assistive role in health care that enhances human intelligence rather than replaces it, according to a new physician survey by the American Medical Association (AMA). However, the survey findings show we are at a critical juncture with an equal number of physicians excited and concerned about the potential for AI. The survey provides deep insight into physician sentiment towards health care AI, including motivations, opportunities, concerns, requirements, and current uses of health care AI.
“Physicians are optimistic about the advantages that properly designed AI-enabled tools can have for patient care, and nearly two-thirds of physicians see an advantage to AI if key requirements are met,” said AMA President Jesse M. Ehrenfeld, M.D., M.P.H. who is board certified in both anesthesiology and clinical informatics. “The AMA survey illustrates that physicians’ greatest hope for AI rests in reducing the crushing administrative burdens that plague modern medicine, which drain health care resources and pull physicians away from patient care.”
The AMA’s Augmented Intelligence Research surveyed 1,081 physicians in August 2023 to investigate the sentiment of practicing physicians regarding the increase usage of AI in health care. The physician sentiments identified in the AMA survey provide insider knowledge to build AI tools around meeting the current needs and requirements of clinicians.
Among the key findings, the physician survey showed:

  • The potential for health care AI has 41% of physicians equally excited and concerned.
  • Enthusiasm was highest for AI tools that help reduce administrative burdens, including documentation (54%) and prior authorization (48%).
  • AI tools were most helpful for enhancing diagnostic ability (72%), workflow efficiency (69%) and clinical outcomes (61%).
  • Concern was highest for AI tools that impact the patient-physicians relationship (39%) and patient privacy (41%).
  • The top attributes required to advance physician adoption of AI tools were data privacy assurances (87%) and not being held liable for AI model errors (87%).
  • AI tools were in use by 38% of physicians with the most common uses including: creation of discharge instructions, care plans, or progress notes (14%), documentation of billing codes, medical charts or visit notes (13%), translation services (11%), and assistive diagnosis (11%).
  • Transparency is key for AI tools with about 80% of physicians indicated they want clear information about key characteristics and features regarding the design, development, and deployment of AI tools.

The AMA’s work continues to support the development of high-quality, clinically validated AI that is deployed in a responsible, ethical, and transparent manner with patient safety being the first and foremost concern. The AMA is dedicated to shaping a future that ensures only safe, high-quality, and unbiased AI products are brought to market and has issued a new set of AI principles to guide the responsible development and deployment and use of AI, ensuring that these technologies contribute positively to the future of health care.

For more information: www.ama-assn.org


Related Content

News | Cardiovascular Business

July 29, 2024 — Edwards Lifesciences announced investments that reflect the company’s deep commitment to advancing ...

Home July 29, 2024
Home
News | Cardiovascular Business

July 18, 2024 — Circle Cardiovascular Imaging, a developer of artificial intelligence (AI)-driven cardiovascular imaging ...

Home July 18, 2024
Home
News | Cardiovascular Business

July 15, 2024 — Guidehealth, an artificial intelligence (AI)-enabled healthcare services company, has announced a ...

Home July 15, 2024
Home
News | Cardiovascular Business

July 15, 2024 — Edwards Lifesciences announced it has exercised its option to acquire Innovalve Bio Medical Ltd., an ...

Home July 15, 2024
Home
News | Cardiovascular Business

July 11, 2024 — Medical device company R3 Vascular Inc., developer of novel, best-in-class bioresorbable scaffolds for ...

Home July 11, 2024
Home
News | Cardiovascular Business

July 9, 2024 — Disparities in cardiovascular disease outcomes between urban and rural areas continue to widen, yet ...

Home July 09, 2024
Home
Feature | Cardiovascular Business

The DAIC team wishes you a safe and happy 4th of July!

Home July 04, 2024
Home
News | Cardiovascular Business

July 3, 2024 — Over the past decade, 342 cardiology clinics have been acquired by private equity firms, with over 94% of ...

Home July 03, 2024
Home
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

From FDA approvals to new clinical trials, here is a look at DAIC's top-read content during the month of June: 1 ...

Home July 02, 2024
Home
News | Cardiovascular Business

July 1, 2024 — CVRx, Inc., a commercial-stage medical device company, announced three additions to its senior leadership ...

Home July 01, 2024
Home
Subscribe Now